Merck Serono Plans Lab In China | Chemical & Engineering News
Volume 89 Issue 38 | p. 17 | Concentrates
Issue Date: September 19, 2011

Merck Serono Plans Lab In China

Department: Business
Keywords: CRO, personalized medicine, Beijing

Merck Serono is setting up its China R&D lab within the site of Pharmaron’s new campus at the Beijing Economic & Technological Development Area. The new lab will focus on clinical bioanalysis and biomarker characterization in a Chinese population. It will support Merck Serono’s efforts in the area of personalized medicine for cancer and neurodegenerative diseases. Pharmaron is among China’s five largest pharmaceutical contract research organizations.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment